In a filing, Acadia Pharmaceuticals Inc revealed its EVP, CHIEF FINANCIAL OFFICER Schneyer Mark C. unloaded Company’s shares for reported $0.55 million on Aug 18 ’25. In the deal valued at $25.18 per share,22,000 shares were sold. As a result of this transaction, Schneyer Mark C. now holds 40,130 shares worth roughly $1.0 million.
Then, Schneyer Mark C. bought 22,000 shares, generating $557,260 in total proceeds.
Before that, Brege Laura sold 14,446 shares. Acadia Pharmaceuticals Inc shares valued at $314,634 were divested by the Director at a price of $21.78 per share. As a result of the transaction, Brege Laura now holds 15,095 shares, worth roughly $0.38 million.
Deutsche Bank upgraded its Acadia Pharmaceuticals Inc [ACAD] rating to a Buy from a a Hold in a research note published recently. A number of analysts have revised their coverage, including Deutsche Bank’s analysts, who began to cover the stock in mid February with a ‘”a Hold”‘ rating. Guggenheim also remained covering ACAD and has decreased its forecast on January 03, 2025 with a “Neutral” recommendation from previously “Buy” rating.
Price Performance Review of ACAD
On Tuesday, Acadia Pharmaceuticals Inc [NASDAQ:ACAD] saw its stock fall -0.36% to $24.97. Over the last five days, the stock has lost -1.89%. Acadia Pharmaceuticals Inc shares have risen nearly 62.14% since the year began. Nevertheless, the stocks have risen 36.08% over the past one year. While a 52-week high of $25.88 was reached on 08/12/25, a 52-week low of $13.40 was recorded on 04/09/25.
Levels Of Support And Resistance For ACAD Stock
The 24-hour chart illustrates a support level at 24.70, which if violated will result in even more drops to 24.44. On the upside, there is a resistance level at 25.28. A further resistance level may holdings at 25.60.
How much short interest is there in Acadia Pharmaceuticals Inc?
A steep rise in short interest was recorded in Acadia Pharmaceuticals Inc stocks on 2025-07-31, dropping by -1.79 million shares to a total of 11.03 million shares. Yahoo Finance data shows the prior-month short interest on 2025-06-30 was 12.83 million shares. There was a decline of -16.27%, which implies that there is a negative sentiment for the stock.
